Birinci Yılında COVID-19 Güncellemesi

Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742.

Xiaolu T, Changcheng W, Xiang L, Yuhe S, Xinmin Y, Xinkai W, Duan Y, Zhang H, Wang Y, Qian Z, Cui J, Lu J. On the origin and continuing evolution of SARS-CoV-2. Nat Sci Rev. 2020;7:1012-23.

COVID-19 Coronavirus Pandemic Updates. Last Accessed date: 18.03.2021. Available from: https://www.worldometers.info/coronavirus/

Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev. 2000;14:291-301.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809-15.

Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun. 2020;11:5761.

Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, Choolani M, Mattar C, Su LL. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222:521-31.

Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. 2017;1:33-46.

Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. Preprints.org. 2020.

Sahin E, Bozdayi G, Yigit S, Muftah H, Dizbay M, Tunccan OG, Fidan I, Caglar K. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins. J Med Virol. 2021;93:6016–26.

Van Tan L, Thi Thu Hong N, My Ngoc N, Tan Thanh T, Thanh Lam V, Anh Nguyet L, Nguyen Truc Nhu L, Thi Ha Ny N, Ngoc Quang Minh N, Nguyen Huy Man D, Thi Ty Hang V, Nguyen Quoc Khanh P, Chanh Xuan T, Thanh Phong N, Nguyen Hoang Tu T, Tinh Hien T, Manh Hung L, Thanh Truong N, Min Yen L, Thanh Dung N, Thwaites G, Van Vinh Chau N; for OUCRU COVID-19 research group. SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics. J Infect. 2020;81:e175-7.

Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, Tong YG, Shi YX, Ni XB, Liao YS, Li WJ, Jiang BG, Wei W, Yuan TT, Zheng K, Cui XM, Li J, Pei GQ, Qiang X, Cheung WY, Li LF, Sun FF, Qin S, Huang JC, Leung GM, Holmes EC, Hu YL, Guan Y, Cao WC. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583:282-5.

Wahba L, Jain N, Fire AZ, Shoura MJ, Artiles KL, McCoy MJ, Jeong DE. An Extensive Meta-Metagenomic Search Identifies SARS-CoV-2-Homologous Sequences in Pangolin Lung Viromes. mSphere. 2020;5:e00160-20.

Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682.

Severe Covid-19 GWAS Group, Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, Grimsrud MM, Milani C, Aziz F, Kässens J, May S, Wendorff M, Wienbrandt L, Uellendahl-Werth F, Zheng T, Yi X, de Pablo R, Chercoles AG, Palom A, Garcia-Fernandez AE, Rodriguez-Frias F, Zanella A, Bandera A, Protti A, Aghemo A, Lleo A, Biondi A, Caballero-Garralda A, Gori A, Tanck A, Carreras Nolla A, Latiano A, Fracanzani AL, Peschuck A, Julià A, Pesenti A, Voza A, Jiménez D, Mateos B, Nafria Jimenez B, Quereda C, Paccapelo C, Gassner C, Angelini C, Cea C, Solier A, Pestaña D, Muñiz-Diaz E, Sandoval E, Paraboschi EM, Navas E, García Sánchez F, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Blasi F, Téllez L, Blanco-Grau A, Hemmrich-Stanisak G, Grasselli G, Costantino G, Cardamone G, Foti G, Aneli S, Kurihara H, ElAbd H, My I, Galván-Femenia I, Martín J, Erdmann J, Ferrusquía-Acosta J, Garcia-Etxebarria K, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Terranova L, Moreira L, Santoro L, Scudeller L, Mesonero F, Roade L, Rühlemann MC, Schaefer M, Carrabba M, Riveiro-Barciela M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Acosta-Herrera M, D’Angiò M, Baldini M, Cazzaniga M, Schulzky M, Cecconi M, Wittig M, Ciccarelli M, Rodríguez-Gandía M, Bocciolone M, Miozzo M, Montano N, Braun N, Sacchi N, Martínez N, Özer O, Palmieri O, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Rodrigues PM, Blandino Ortiz A, de Cid R, Ferrer R, Gualtierotti R, Nieto R, Goerg S, Badalamenti S, Marsal S, Matullo G, Pelusi S, Juzenas S, Aliberti S, Monzani V, Moreno V, Wesse T, Lenz TL, Pumarola T, Rimoldi V, Bosari S, Albrecht W, Peter W, Romero-Gómez M, D’Amato M, Duga S, Banales JM, Hov JR, Folseraas T, Valenti L, Franke A, Karlsen TH. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383:1522-34.

Song CM, Lim SJ, Tong JC. Recent advances in computer-aided drug design. Brief Bioinform. 2009;10:579-91.

Ray M, Sable MN, Sarkar S, Hallur V. Essential interpretations of bioinformatics in COVID-19 pandemic. Meta Gene. 2021;27:100844.

Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, Semple C. NERVTAG Note on B.1.1.7 Severity. Scientific Advisory Groups for Emergencies (SAGE) meeting paper. London: SAGE; 2021. Last Accessed date: February 11, 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/955239/NERVTAG_paper_on_variant_of_concern__VOC__B.1.1.7.pdf

Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM, Nussenzweig MC, Hatziioannou T, Bieniasz PD. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020;9:e61312.

Resende PC, Bezerra JF, de Vasconcelos RHT, Arantes I, Appolinario L, Mendonça AC, Paixao AC, Rodrigues ACD, Silva T, Rocha AS, Pauvolid-Corrêa AP, Motta FC, Teixeira DLF, Carneiro TFDO, Neto FPF, Herbster ID, Leite AB, Riediger IN, Debur MDC, Naveca FG, Almeida W, Livorati M, Bello G, Siqueira MM. Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020. Last Accessed date: February 11, 2021. Available from: https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584

Science Brief: Emerging SARS-CoV-2 Variants, Updated Jan. 28, 2021. Last Accessed date: September 15, 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html

Koronavirüs Bilim Kurulu Toplantısına İlişkin Açıklama (31.03.2021). Last Accessed date: 15.09.2021. Available from: https://www.saglik.gov.tr/TR,82118/koronavirus-bilim-kurulu-toplantisina-iliskin-aciklama-31032021.html

Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gü mü ş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM; Sinai Immunology Review Project. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52:910-41.

Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology. 2020;225:152008.

Ebrahimi N, Aslani S, Babaie F, Hemmatzadeh M, Hosseinzadeh R, Joneidi Z, Mehdizadeh Tourzani Z, Pakravan N, Mohammadi H. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics. Int Immunopharmacol. 2020;89:107082.

McKechnie JL, Blish CA. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? Cell Host Microbe. 2020;27:863-9.

Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861-80.

T.C. Sağlık Bakanlığı 2020. Son Erişim tarihi: 30.12.2020. Erişim adresi: https://covid19.saglik.gov.tr/TR-66337/genel-bilgiler-epidemiyoloji-vetani.html

World Health Organization (WHO). 2020. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Last Accessed date: 30.12.2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Senol C, Bilsel A. Status of COVID-19 (Coronavirus) Pandemic in Turkey and Future Status Analysis According to Algorithmic Calculation. Journal of Social, Humanities and Administrative Sciences. 2020;6:535-46.

Ünal I, Gereklioglu C, Bozdemir N. Dü nyada ve Tü rkiye’de COVID-19: Epidemiyolojik Veriler. Arşiv Kaynak Tarama Dergisi. 2020;29:2-10.

Abdullahi AM, Sarmast ST. Coronavirus Disease of the 2019 (Covid-19): Virology, Epidemiology, Pathogenesis, Clinical Presentation, Diagnosis and Treatment. J Diagn Cas Rep. 2020;1:1-6.

Kuşcu F, Taşova Y. Clinical Features and Managament of COVID-19. Archives Medical Review Journal. 2020;29(Supplement 1):24-30.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-74.

Bulbul A, Agirgol E, Uslu S, Elitok GK, Tellioglu A, Avsar H, Divarci A, Bas EK, Unal ET. COVID-19 Management in Newborn Babies in the Light of Recent Data: Breastfeeding, Rooming-in and Clinical Symptoms. Sisli Etfal Hastan Tip Bul. 2020;54:261-70.

Bullard J, Dust K, Funk D, Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, Boodman C, Bello A, Hedley A, Schiffman Z, Doan K, Bastien N, Li Y, Van Caeseele PG, Poliquin G. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples. Clin Infect Dis. 2020;71:2663-6.

ISARIC Clinical Characterisation Group (2020). COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study. medRxiv: the preprint server for health sciences, 2020.10.26.20219519. Available from: https://doi.org/10.1101/2020.10.26.20219519

Akyıldız HÇ, Özmen A, Kiraz EDE. Evaluation of Covid-19 From Climate Change And Gender Perspective. City Health Journal. 2020;1:6-11.

Yuan S, Jiang SC, Li ZL. Analysis of Possible Intermediate Hosts of the New Coronavirus SARS-CoV-2. Front Vet Sci. 2020;7:379.

Chang L, Yan Y, Wang L. Coronavirus Disease 2019: Coronaviruses and Blood Safety. Transfus Med Rev. 2020;34:75-80.

Goyal N, Chung M, Bernheim A, Keir G, Mei X, Huang M, Li S, Kanne JP. Computed Tomography Features of Coronavirus Disease 2019 (COVID-19): A Review for Radiologists. J Thorac Imaging. 2020;35:211-8.

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA, Jacobi A, Li K, Li S, Shan H. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020;295:202-7.

Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, Little BP, Rubin GD, Sverzellati N. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299:E262-79.

Waller JV, Allen IE, Lin KK, Diaz MJ, Henry TS, Hope MD. The Limited Sensitivity of Chest Computed T

Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Updated Feb. 16, 2021. Last Accession date: 15.09.2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

Wu R, Wang L, Kuo HD, Shannar A, Peter R, Chou PJ, Li S, Hudlikar R, Liu X, Liu Z, Poiani GJ, Amorosa L, Brunetti L, Kong AN. An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports. 2020;6:56-70.

T.C. Sağlık Bakanlığı. COVID-19 (SARS-CoV-2 Enfeksiyonu), Erişkin Hasta Tedavisi. Last Accessed date: 16.09.2021. Available from: https://covid19.saglik.gov.tr/Eklenti/40719/0/covid-19rehberieriskinhastayonetimivetedavipdf.pdf

Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:e325-31.

Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I, Sacco E, Naccache JM, Bézie Y, Laplanche S, Le Berre A, Le Pavec J, Salmeron S, Emmerich J, Mourad JJ, Chatellier G, Hayem G. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020;2:e393-400.

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. Last Accessed date: 05.03.2021. Available from: https://www.covid19treatmentguidelines.nih.gov/tables/table-3a/

World Health Organization (WHO). Corticosteroids for COVID-19. Last Accessed date: 12.03.2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1

Prescott HC, Rice TW. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic. JAMA. 2020;324:1292-5.

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. Immunomodulators under evaluation for the treatment of COVID-19. Last Accessed date: 12.03.2021. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/section/section_114.pdf

Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O’Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Infectious Diseases Society of America 2021; Version 4.1.0. Last Accessed date: 12.03.2021. Available from: https://www.idsociety.org/practiceguideline/covid-19-guideline-treatment-and-management/

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020;383:120-8.

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. American Society of Hematology. COVID-19 and VTE/Anticoagulation: Frequently Asked Questions. Spyropoulos. J Thromb Haemost. 2020;18:1859. Available from: https://www.hematology.org/covid-19/covid-19-and-vteanticoagulation

Ling Li, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients with Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA. 2020;324:460-70.

Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K, Chung KM, Hermann A, Ullman E, Cruz J, Rafique A, Huang T, Fairhurst J, Libertiny C, Malbec M, Lee WY, Welsh R, Farr G, Pennington S, Deshpande D, Cheng J, Watty A, Bouffard P, Babb R, Levenkova N, Chen C, Zhang B, Romero Hernandez A, Saotome K, Zhou Y, Franklin M, Sivapalasingam S, Lye DC, Weston S, Logue J, Haupt R, Frieman M, Chen G, Olson W, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 2020;369:1010-4.

Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, Oakley G, Schade AE, Sabo J, Patel DR, Klekotka P, Skovronsky DM; BLAZE-1 Investigators. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med. 2021;384:229-37.

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. Anti-SARS-CoV-2 Antibody Products. Last Accessed date: 12.03.2021. Available from: https://www.covid19treatmentguidelines.nih.gov/statement-onbamlanivimab-eua/

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. Supplements. Last Accessed date: 12.03.2021. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/vitamin-c/

te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6:e1001176.

Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients. 2020;12:1181.

Carlucci P, Ahuja T, Petrilli CM, Rajagopalan H, Jones S, Rahimian J. Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients. medRxiv. Last Accessed date: 2020 May 8. Available from: https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1

National Institutes of Health (NIH). COVID-19 Treatment Guidelines. Supplements. Last Accessed date: 12.03.2021. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/zinc/

Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Fernandez-Pittol M, Pitart C, Inciarte A, Bodro M, Morata L, Ambrosioni J, Grafia I, Meira F, Macaya I, Cardozo C, Casals C, Tellez A, Castro P, Marco F, García F, Mensa J, Martínez JA, Soriano A; COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27:83-8.

T.C. Sağlık Bakanlığı. COVID-19 Rehberi. Last Accessed date: 03.03.2021. Available from: www.saglik.gov.tr./covid19rehber/

Tezcan SG. Temel Epidemiyoloji, Ankara: Hipokrat Kitabevi; 2017.

Demirtaş T, Tekiner H. Filiation: A Historical Term the COVID-19 Outbreak Recalled in Turkey. Erciyes Med J. 2020;42:354-8.

Tom Frieden. Online Global Consultation on Contact Tracing for COVID-19. Resolve to Save Lives. COVID-19 Contact Tracing Playbook 2020. Last Accessed date: 05.03.2021. Available from: https://firebasestorage.googleapis.com/v0/b/export-gitbook/o/spaces%2F-M6GdgxKtmqDui0D155D%2Fpdf%2F2972847956.pdf?generation=1610099378048340&alt=media

World Health Organization (WHO). Types of Vaccine. Module 1: Introduction to Vaccine Safety. Last Accessed date: 06.03.2021. Available from: http://vaccine-safety-training.org/types-of-vaccine-overview.html

Haque A, Pant AB. Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines (Basel). 2020;8:739.

Centers for Disease Control and Prevention (CDC). What Clinicians Need to Know About the Pfizer-BioNTech COVID-19 Vaccine. Last Accessed date: 05.03.2021. Available from: https://www.cdc.gov/vaccines/covid-19/downloads/pfizer-biontech-vaccine-what-Clinicians-need-to-know.pdf

Selçuk Üniversitesi. Kurumsal İletişim Koordinatörlüğü. Selçuk Üniversitesi aşı çalışmaları Dünya Sağlık Örgütü listesinde. Son Erişim tarihi: 11.03.2021. Erişim adresi: https://selcuk.edu.tr/HaberKulturSporDetay/2020-selcukuniversitesi-asi-calismalari-dunya-saglik-orgutu-listesinde--4504

Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, Luo Y, Chan JF, Sahi V, Figueroa A, Guo XV, Cerutti G, Bimela J, Gorman J, Zhou T, Chen Z, Yuen KY, Kwong PD, Sodroski JG, Yin MT, Sheng Z, Huang Y, Shapiro L, Ho DD. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450-6.

World Health Organization (WHO). Weekly epidemiological update on COVID-19. Last Accessed date: 27.04.2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19

Abdool Karim SS, de Oliveira T. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications. N Engl J Med. 2021;384:1866-8.

Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27:315-8.

BBC News. Sinovac: Brazil Results show Chinese Vaccine 50.4% Effective. BBC News, 13 January 2021.

Dyer O. COVID-19: Chinese vaccines may need changes to improve efficacy, admits official. BMJ. 2021;373:n969.

Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%. Last Accessed date: 24.04.2021. Available from: https://www.bharatbiotech.com/images/press/covaxin-phase3-efficacy-results.pdf

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials. Last Accessed date: 24.04.2021. Available from: https://ir.novavax.com/news-releases/news-release-details/novavax-confirms-high-levels-efficacy-againstoriginal-and-0

Pfizer and Biontech Confirm High Efficacy and No Serious Safety Concerns Through Up To Six Months Following Second Dose in Updated Topline Analysis Of Landmark COVID-19 Vaccine Study. Last Accessed date: 24.04.2021. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-confirm-high-efficacy-and-noserious

Moderna COVID-19 Vaccine Overview and Safety. Last Accessed date: 24.04.2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7): An Exploratory Analysis of a Randomized Controlled Trial. Lancet 2021;Epub ahead of print.

Gibran Naiyyar Peshimam. CanSino BIO’s COVID-19 Vaccine 65.7% Effective in Global Trials, Pakistan Official Says. Reuters;2021.

Roxby P. Russian Covid Vaccine Shows Encouraging Results. BBC News;2020.

U.S. Food and Drug Administration. COVID-19 Vaccine Ad26.COV2.S, VAC31518 (JNJ-78436735)—Sponsor Briefing Document; FDA: White Oak,MD, USA, 2021.

Kahraman EP, Altındiş M. COVID-19 Aşıları; Pandemide Sona Doğru? J Biotechnol and Strategic Health Res. 2020;4:240-9.